4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000010
Chief Executive Officer sold 12,066 shares at $22.99 ($277,397)
- Chief Executive Officer acquired 25,527 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goff Brian · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +25,527 | 52,119 | D | ||
| 2024-01-09 | Sale : show line 2 in the form 10b5-1 | −12,066 | $22.99 | $277,397 | 40,053 | D |
| Open-market sales · 12,066 sh · avg $22.99 · $277,397 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-05 | Exercise or conversion : show line 3 in the form 10b5-1 Performance share units | −25,527 | 119,128 | D |
Loading xslF345X05/wk-form4_1704835697.xml…